Results 11 to 20 of about 193,296 (299)

Observed benefits of a major trauma centre in a tertiary hospital in Nigeria

open access: yesAfrican Journal of Emergency Medicine, 2021
Introduction: A Trauma System or its components has been shown to improve trauma services and outcome of seriously injured patients. These organised services are non0existent or the components operate in isolation in most African countries.This study was
Usman Adamu Gwaram   +2 more
doaj   +1 more source

Geographical challenges and inequity of healthcare access for high-risk paediatric heart disease

open access: yesInternational Journal for Equity in Health, 2023
Background Geographical context is an important consideration for health system design to promote equality in access to care for patients with childhood heart disease (CHD), particularly those living in regional, rural, and remote areas.
Benjamin C. Auld   +3 more
doaj   +1 more source

Reply to: Management of cardiac arrest in specialist centres [PDF]

open access: yesResuscitation, 2019
Non peer ...
Joyce Yeung   +2 more
openaire   +4 more sources

Weekly Paclitaxel given concurrently with Durvalumab has a favorable safety profile in triple-negative metastatic breast cancer

open access: yesScientific Reports, 2021
Therapeutic anti-PD-L1 antibodies are safe as a monotherapy, albeit with minimal efficacy in triple-negative breast cancer (TNBC). This trial aimed to test the safety and efficacy of Durvalumab and Paclitaxel in metastatic TNBC.
Hazem Ghebeh   +7 more
doaj   +1 more source

Reducing Central-Line–Associated Bloodstream Infections (CLABSI): An Improvement Project in a Specialized Tertiary Hospital [PDF]

open access: yesGlobal Journal on Quality and Safety in Healthcare, 2022
Introduction: Central-line–associated bloodstream infections (CLABSI) are preventable hospital-acquired infections that harm and prolong a patient's hospital stay and increase unnecessary hospital expenditure.
Fadwa Abu Mostafa   +5 more
doaj   +1 more source

PD-L1 is overexpressed on breast cancer stem cells through notch3/mTOR axis

open access: yesOncoImmunology, 2020
The T-cell inhibitory molecule PD-L1 is expressed on a fraction of breast cancer cells. The distribution of PD-L1 on the different subpopulations of breast cancer cells is not well-defined.
Fatmah A. Mansour   +4 more
doaj   +1 more source

Prevalence and timing of specialist palliative care access among advanced cancer patients and association with hospital death

open access: yesProceedings of Singapore Healthcare, 2022
Background Patients with advanced cancer have poor quality of life and high utilisation of acute healthcare services. Early access to palliative care has been shown to improve quality of life as well as reduce acute healthcare utilisation and costs ...
Grace Meijuan Yang   +3 more
doaj   +1 more source

ACQUIRED FACTOR XIII DEFICIENCY WITH RUNX1 MUTATION, A REPORT OF TWO CASES TREATED WITH FACTOR XIII CONCENTRATE

open access: yesHematology, Transfusion and Cell Therapy, 2021
Acquired FXIII deficiency has been described in association with malignancies or autoimmune disorders. We report two cases of acquired FXIII deficiency associated with hematologic malignancies.
Alfadil Haroon   +4 more
doaj   +1 more source

Trauma Specialist Centres [PDF]

open access: yesThe Bulletin of the Royal College of Surgeons of England, 2007
In 2011 it will be 50 years since the Osmond-Clarke report first proposed a network of specialist units to care for injured patients across England and Wales. Since that time there have been multiple aborted attempts to implement regionalisation of trauma care. For the first time in half a century the clinical imperative now appears to be supported by
openaire   +1 more source

HCV infection should be managed in specialist centres [PDF]

open access: yesGut, 2002
Chronic hepatitis C virus (HCV) infection may cause slowly progressive chronic hepatitis, cirrhosis, advanced liver failure, and hepatocellular carcinoma.1 These varying outcomes of type C hepatitis pose a challenge and responsibility which requires firstly, that antiviral treatment is targeted as precisely as possible to those who have progressive ...
openaire   +5 more sources

Home - About - Disclaimer - Privacy